headerseite_erythrozyten
headerseite_binaer
headerseite_nerv4
headerseite_bakterien
headerseite_neurotrans
headerseite_wabe
headerseite_nerv1
headerseite_nerv1b
headerseite_nerv2
headerseite_chip
headerseite_dna
headerseite_befruchtung
headerseite_nerv3

transcan2The ERA-NET on Translational Cancer Research (TRANSCAN) was established to coordinate research efforts and funding programmes of European countries in translational cancer research. In December new calls will be published under the topic: „Validation of biomarkers for personalised cancer medicine“.

The call will support the development of transnational innovative projects in oncology, clearly oriented towards a rapid application of new and more selective and effective tools and strategies for the prevention, diagnosis and early detection, as well as optimising therapy of neoplastic diseases. This should be achieved in close cooperation between academic, clinical, epidemiological or public health research teams and industry. The research teams within a consortium should include investigators of all scientific disciplines, research areas and expertises necessary to achieve the proposed objectives.

For more information see: http://www.transcanfp7.eu/transcan/